CIK 0001875091 · Non-accelerated filer<br>Emerging growth company
NeuroSense Therapeutics Ltd.
Sign in to watch- Ticker
- NRSN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- other
- Phone
- 972-9-9531142
- Business address
- 11 HAMENOFIM ST., BUILDING B, HERZLIYA, Israel, 4672562
Securities
- NRSN Ordinary Shares Nasdaq
- NRSNW Warrant Nasdaq
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 6-K Event Report of Foreign Issuer
- 20-F Report Annual and Transition Report of Foreign Private Issuers
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 6-K Event Report of Foreign Issuer
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 2 of 16 · 314 filings